Click here to go to the Novaflux main page.
Who we are





Novaflux Technologies, formerly Princeton Trade & Technology, Inc., is a New Jersey based company, incorporated in 1988, with the primary goal of developing and commercializing medical devices and pharmaceutical products for domestic and international markets. Presently, the company is actively developing new applications for its patented breakthrough two-phase flow cleaning technology platform. Development of several products in the medical, dental, pharmaceutical, food processing and water treatment fields is underway. Many such products are in the process of being commercialized. Novaflux’s innovations have been peer reviewed and recognized in the form of multiple grants and contracts from National Institutes of Health, United States Air Force, United States Navy, New Jersey Commission on Science and Technology, Bureau of Reclamation – Department of the Interior, United States Department of Agriculture, and the Industrial Sector, both in the United States and Internationally.

Our main offices and laboratories are located at 1 Wall Street, Princeton, New Jersey 08540. Various in-vitro and clinical studies have been performed or are in preparation at the facilities of the University of Maryland Dental School, the University of Medicine and Dentistry of New Jersey, Georgetown University Medical School, Jefferson University Medical School, Baylor College of Dentistry - Texas A & M University, University of Delaware, Pennsylvania State University, Wayne State University, University of Louisville, University of Utah, University of Pennsylvania and at our pilot testing facilities in New Jersey. Supporting validation of technology has been performed in collaboration with several academic and industrial partners.

The company’s staff consists of highly skilled full and part-time professionals with expertise in the fields of medicine, dentistry, chemistry, mechanical engineering, chemical engineering, microbiology, physics, transport phenomena, colloid science, membrane science and others. The full-time staff has extensive management experience that includes directing product development projects. The core of full-time staff members, part-time staff members, and consultants mesh nicely to form a close-knit working atmosphere with information sharing and progress being at the top of the agenda.




  • Mohamed E. Labib, Ph.D. in Chemistry, McGill University, President and Founder

  • Richard F. Stockel, Ph.D. in Organic Chemistry, Clemson University, Vice President of Technology

  • Richard (C.-Y.) Lai, Ph.D. in Mechanical Engineering, University of Pittsburgh, Director of Research and Development

  • Yacoob Tabani, Ph.D. in Mechanical Engineering, New Jersey Institute of Technology, Senior Engineer

  • Steven A. Weitzel, B.S. in Chemical Engineering, University of Missouri, Director of Marketing

  • Jay Qian, M.S. in Mechanical Engineering, City College of New York (CUNY), Mechanical Engineer

  • Joseph J. Murawski, B.S. in Physics and Fine Arts, New York University, Process Engineer

  • Charles Giambrone, M.S. in Microbiology, Rutgers University, Senior Microbiologist




    Part-time collaborators in major projects and private consultants include the following:

    • Henry Williams, Ph.D., Professor of Microbiology, University of Maryland Dental School – Development of Dental Unit Waterlines Technology and PI of Clinical Studies at UMAB.

    • Stanley Benjamin, M.D., Chief of Gastroenterology, Georgetown Medical School – Collaborator and advisor in programs for the development of flexible endoscope cleaning and reprocessing.

    • Stanislav S. Dukhin, Ph.D., Primary Consultant in fluid dynamics, transport phenomena, cleaning physics, system design, theoretical formulation of processes, analysis and formulation of novel ideas and products.

    • Robert Kolstad, Ph.D., Professor of Microbiology, Baylor College of Dentistry – PI of clinical studies and validation of high-speed dental handpiece cleaning, disinfection and sterilization.

    • Walter Bond, M.S., Former Supervisory Research Microbiologist, Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, now an independent consultant in heathcare-related environmental microbiology, RCSA, Inc., Lawrenceville, GA – Advisor in the development of products based on the patented Novaflux process, and collaborator in several NIH funded projects.

    • Richard Sherman, M.D., Medical Director of Dialysis Centers International (DCI), Professor of Nephrology, Robert Wood Johnson Medical School (UMDNJ) – PI and collaborator in the development of hemodialyzer reprocessing technology including clinical trials.

    • Toros Kaponian, M.D., Professor of Nephrology, Robert Wood Johnson Medical School (UMDNJ) – PI in clinical study for the development of hemodialyzer reprocessing technology.

    • Richard A. Ward, Ph.D., Professor of Medicine and Head of Kidney Disease Program, University of Louisville – PI in clinical study for the development of hemodialyzer reprocessing technology.

    • Michelle J. Alfa, Ph.D., Professor of Clinical Microbiology, Dept. of Clinical Laboratory Science, The College of Pharmacy & Applied Health Professions, Wayne State University – PI in clinical study for the development of flexible endoscope cleaning and reprocessing technology.

    • Anthony J. DiMarino, Jr., M.D., Chief, Division of Gastroenterology & Hepatology, Thomas Jefferson University Medical School – PI in clinical study for the development of flexible endoscope cleaning and reprocessing .

    • Donald Jungkind, Ph.D., Director, Clinical Microbiology, Dept. of Pathology, Thomas Jefferson University – Co-PI in clinical study for the development of endoscope cleaning and reprocessing technology.

    • Andrew L. Zydney, Ph.D., Professor, Department of Chemical Engineering, Pennsylvania State University, and formerly with the University of Delaware – PI on joint programs for the development of hemodialyzer reprocessing technology; other consulting activities in membrane cleaning and applications.

    • Brian Wigdahl, Ph.D., Professor and Director, Department of Microbiology and Immunology, Pennsylvania State University College of Medicine – PI in pre-clinical study for the development of microbiocides for preventing HIV transmission.

    • Mary K. Howett, Ph.D., Professor, Department of Microbiology and Immunology, Pennsylvania State University College of Medicine – Co-PI in pre-clinical study for the development of microbiocides for preventing HIV transmission.

    • Fred C. Krebs, Ph.D., Assistant Professor, Department of Microbiology and Immunology, Pennsylvania State University College of Medicine – Co-PI in pre-clinical study for the development of microbicides for preventing HIV transmission.

    • Jeffrey J. Morrell, Professor, Department of Forest Products, Oregon State University – PI for the development of environmentally-safe wood preservatives.




    Click here to see who we've been working with and what we've been doing lately.



  • Back to Novaflux home